Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 4595 composition records across product categories including Personal care, Construction, Food and drug.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of HYALURONATE SODIUM in our catalog (epa_cpdat).
Products
4,595
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 4595 composition records across product categories including Personal care, Construction, Food and drug. EPA CPDat classifies this chemical for functional uses including Softener and conditioner, Humectant.
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 23 mg
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 23 mg
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 23 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 463 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 0.01 %w/w
US
FDA
FDA NDC lists this ingredient in 3 active drug products and 4 total products.
US
FDA
FDA NDC lists this ingredient in 11 active drug products and 11 total products.
US
FDA
openFDA substance registry classifies this ingredient as polymer.